The results of univariate and multivariate analyses showed that high UBE2C mRNA expression was strongly associated with poor DFS, DMFS, and OS only in patients with HR+/HER2– pN0 and pN1 (early) breast cancer but not in those with pN2/N3 (late) breast cancer. Here, UBE2C is linked to breast carcinoma.